Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1575

1.

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.

Danser AHJ, Epstein M, Batlle D.

Hypertension. 2020 Mar 25:HYPERTENSIONAHA12015082. doi: 10.1161/HYPERTENSIONAHA.120.15082. [Epub ahead of print]

PMID:
32208987
2.

Use of the WatchPAT to Detect Occult Residual Sleep-Disordered Breathing in Patients on CPAP for Obstructive Sleep Apnea.

Epstein M, Musa T, Chiu S, Costanzo J, Dunne C, Cerrone F, Capone R.

J Clin Sleep Med. 2020 Mar 2. doi: 10.5664/jcsm.8406. [Epub ahead of print]

PMID:
32118574
3.

Prolonging gavage feeds for reduction of gastroesophageal reflux in infants.

Favara MT, Abraham S, DiPalma J, Epstein M, Greenspan JS, Aghai ZH.

J Perinatol. 2020 Feb 21. doi: 10.1038/s41372-020-0630-4. [Epub ahead of print]

PMID:
32086438
4.

Correction to: Association between nocturia and frailty among elderly males in a veterans administration population.

Monaghan TF, Wagg AS, Bliwise DL, Agudelo CW, Michelson KP, Rahman SN, Epstein MR, Haddad R, Everaert K, Lazar JM, Weiss JP.

Aging Clin Exp Res. 2020 Jan 2. doi: 10.1007/s40520-019-01456-4. [Epub ahead of print]

PMID:
32077072
5.

Combining whole-school and targeted programs for the reduction of bullying victimization: A randomized, effectiveness trial.

Rapee RM, Shaw T, Hunt C, Bussey K, Hudson JL, Mihalopoulos C, Roberts C, Fitzpatrick S, Radom N, Cordin T, Epstein M, Cross D.

Aggress Behav. 2020 Feb 17. doi: 10.1002/ab.21881. [Epub ahead of print]

PMID:
32064639
6.

Sodium restriction improves nocturia in patients at a cardiology clinic.

Monaghan TF, Michelson KP, Wu ZD, Gong F, Agudelo CW, George CD, Alwis US, Epstein MR, Mekki P, Flores VX, Bliwise DL, Everaert K, Vande Walle J, Weiss JP, Lazar JM.

J Clin Hypertens (Greenwich). 2020 Feb 12. doi: 10.1111/jch.13829. [Epub ahead of print]

7.

Phenotyping nocturnal polyuria: circadian and age-related variations in diuresis rate, free water clearance and sodium clearance.

Monaghan TF, Bliwise DL, Denys MA, Goessaert AS, Decalf V, Kumps C, Vande Walle J, Weiss JP, Epstein MR, Weedon J, Lazar JM, Everaert K.

Age Ageing. 2020 Feb 10. pii: afz200. doi: 10.1093/ageing/afz200. [Epub ahead of print]

PMID:
32043123
8.

Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion.

Cleynen I, Engchuan W, Hestand MS, Heung T, Holleman AM, Johnston HR, Monfeuga T, McDonald-McGinn DM, Gur RE, Morrow BE, Swillen A, Vorstman JAS, Bearden CE, Chow EWC, van den Bree M, Emanuel BS, Vermeesch JR, Warren ST, Owen MJ, Chopra P, Cutler DJ, Duncan R, Kotlar AV, Mulle JG, Voss AJ, Zwick ME, Diacou A, Golden A, Guo T, Lin JR, Wang T, Zhang Z, Zhao Y, Marshall C, Merico D, Jin A, Lilley B, Salmons HI, Tran O, Holmans P, Pardinas A, Walters JTR, Demaerel W, Boot E, Butcher NJ, Costain GA, Lowther C, Evers R, van Amelsvoort TAMJ, van Duin E, Vingerhoets C, Breckpot J, Devriendt K, Vergaelen E, Vogels A, Crowley TB, McGinn DE, Moss EM, Sharkus RJ, Unolt M, Zackai EH, Calkins ME, Gallagher RS, Gur RC, Tang SX, Fritsch R, Ornstein C, Repetto GM, Breetvelt E, Duijff SN, Fiksinski A, Moss H, Niarchou M, Murphy KC, Prasad SE, Daly EM, Gudbrandsen M, Murphy CM, Murphy DG, Buzzanca A, Fabio FD, Digilio MC, Pontillo M, Marino B, Vicari S, Coleman K, Cubells JF, Ousley OY, Carmel M, Gothelf D, Mekori-Domachevsky E, Michaelovsky E, Weinberger R, Weizman A, Kushan L, Jalbrzikowski M, Armando M, Eliez S, Sandini C, Schneider M, Béna FS, Antshel KM, Fremont W, Kates WR, Belzeaux R, Busa T, Philip N, Campbell LE, McCabe KL, Hooper SR, Schoch K, Shashi V, Simon TJ, Tassone F, Arango C, Fraguas D, García-Miñaúr S, Morey-Canyelles J, Rosell J, Suñer DH, Raventos-Simic J; International 22q11.2DS Brain and Behavior Consortium, Epstein MP, Williams NM, Bassett AS.

Mol Psychiatry. 2020 Feb 3. doi: 10.1038/s41380-020-0654-3. [Epub ahead of print]

PMID:
32015465
9.

Preclinical biological and physicochemical evaluation of two-photon engineered 3D biomimetic copolymer scaffolds for bone healing.

Kampleitner C, Changi K, Felfel RM, Scotchford CA, Sottile V, Kluger R, Hoffmann O, Grant DM, Epstein MM.

Biomater Sci. 2020 Mar 17;8(6):1683-1694. doi: 10.1039/c9bm01827a.

PMID:
31984995
10.

Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence.

Lee C, Check DK, Manace Brenman L, Kushi LH, Epstein MM, Neslund-Dudas C, Pawloski PA, Achacoso N, Laurent C, Fehrenbacher L, Habel LA.

Breast Cancer Res Treat. 2020 Feb;180(1):219-226. doi: 10.1007/s10549-020-05539-z. Epub 2020 Jan 23.

PMID:
31975315
11.

Knowledge-guided analysis of "omics" data using the KnowEnG cloud platform.

Blatti C 3rd, Emad A, Berry MJ, Gatzke L, Epstein M, Lanier D, Rizal P, Ge J, Liao X, Sobh O, Lambert M, Post CS, Xiao J, Groves P, Epstein AT, Chen X, Srinivasan S, Lehnert E, Kalari KR, Wang L, Weinshilboum RM, Song JS, Jongeneel CV, Han J, Ravaioli U, Sobh N, Bushell CB, Sinha S.

PLoS Biol. 2020 Jan 23;18(1):e3000583. doi: 10.1371/journal.pbio.3000583. eCollection 2020 Jan.

12.

Adult Social Environments and the Use of Combustible and Electronic Cigarettes: Opportunities for Reducing Smoking in the 30s.

Kosterman R, Epstein M, Bailey JA, Oesterle S, Furlong M, Hawkins JD.

Nicotine Tob Res. 2020 Jan 23. pii: ntaa019. doi: 10.1093/ntr/ntaa019. [Epub ahead of print]

PMID:
31970409
13.

Time of peak nocturnal diuresis rate between men with secondary nocturnal polyuria versus nocturnal polyuria syndrome.

Monaghan TF, Epstein MR, Bliwise DL, Michelson KP, Wu ZD, Lazar JM, Everaert K, Kabarriti AE, Holmes A, Wein AJ, Weiss JP.

Neurourol Urodyn. 2020 Feb;39(2):785-792. doi: 10.1002/nau.24283. Epub 2020 Jan 21.

PMID:
31961968
14.

Racial/ethnicity differences in endorsing influential factors for prostate cancer treatment choice: An analysis of data from the personal patient profile-prostate (P3P) I and II trials.

Trinh QD, Hong F, Halpenny B, Epstein M, Berry DL.

Urol Oncol. 2020 Mar;38(3):78.e7-78.e13. doi: 10.1016/j.urolonc.2019.10.015. Epub 2019 Dec 27.

PMID:
31883873
15.

Leveraging Family History in Case-Control Analyses of Rare Variation.

Solis-Lemus CR, Fischer ST, Todor A, Liu C, Leslie EJ, Cutler DJ, Ghosh D, Epstein MP.

Genetics. 2020 Feb;214(2):295-303. doi: 10.1534/genetics.119.302846. Epub 2019 Dec 16.

PMID:
31843756
16.

Is our current understanding and management of nocturia allowing improved care? International Consultation on Incontinence-Research Society 2018.

Hervé F, Abrams P, Bower W, De Wachter S, Epstein M, Lombardo R, Robinson D, Tubaro A, Wein A, Weiss JP, Everaert K.

Neurourol Urodyn. 2019 Dec;38 Suppl 5:S127-S133. doi: 10.1002/nau.23961.

PMID:
31821625
17.

Risk of dementia following androgen deprivation therapy for treatment of prostate cancer.

Krasnova A, Epstein M, Marchese M, Dickerman BA, Cole AP, Lipsitz SR, Nguyen PL, Kibel AS, Choueiri TK, Basaria S, Mucci LA, Sun M, Trinh QD.

Prostate Cancer Prostatic Dis. 2019 Nov 29. doi: 10.1038/s41391-019-0189-3. [Epub ahead of print]

PMID:
31784699
18.

Association between nocturia and frailty among elderly males in a veterans administration population.

Monaghan TF, Wagg AS, Bliwise DL, Agudelo CW, Michelson KP, Rahman SN, Epstein MR, Haddad R, Everaert K, Lazar JM, Weiss JP.

Aging Clin Exp Res. 2019 Nov 23. doi: 10.1007/s40520-019-01416-y. [Epub ahead of print] Erratum in: Aging Clin Exp Res. 2020 Jan 2;:.

PMID:
31760609
19.

Identifying monoclonal gammopathy of undetermined significance in electronic health data.

Epstein MM, Saphirak C, Zhou Y, LeBlanc C, Rosmarin AG, Ash A, Singh S, Fisher K, Birmann BM, Gurwitz JH.

Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):69-76. doi: 10.1002/pds.4912. Epub 2019 Nov 17.

PMID:
31736189
20.

Angioedema in an Immunocompromised Patient.

Balgobind A, Chen T, Epstein M.

Am J Ther. 2019 Oct 28. doi: 10.1097/MJT.0000000000001109. [Epub ahead of print] No abstract available.

PMID:
31688065
21.

Does Adolescent Alcohol Harm Minimization Policy Exposure Reduce Adult Alcohol Problems? A Cross-National Comparison.

Epstein M, Bailey JA, Furlong M, Catalano RF, Toumbourou JW.

J Adolesc Health. 2019 Oct 29. pii: S1054-139X(19)30430-6. doi: 10.1016/j.jadohealth.2019.08.019. [Epub ahead of print]

PMID:
31676227
22.

The "maternal effect" on epilepsy risk: Analysis of familial epilepsies and reassessment of prior evidence.

Ellis CA, Berkovic SF, Epstein MP, Ottman R; Epi4K Consortium.

Ann Neurol. 2020 Jan;87(1):132-138. doi: 10.1002/ana.25625. Epub 2019 Nov 18.

PMID:
31637767
23.

Sleep and fatigue in newly graduated nurses-Experiences and strategies for handling shiftwork.

Epstein M, Söderström M, Jirwe M, Tucker P, Dahlgren A.

J Clin Nurs. 2020 Jan;29(1-2):184-194. doi: 10.1111/jocn.15076. Epub 2019 Oct 31.

PMID:
31609523
24.

Long-Term Patterns of Oral Anticancer Agent Adoption, Duration, and Switching in Patients With CML.

Banegas MP, Rivera DR, O'Keeffe-Rosetti MC, Carroll NM, Pawloski PA, Tabano DC, Epstein MM, Yeung K, Hornbrook MC, Lu C, Ritzwoller DP.

J Natl Compr Canc Netw. 2019 Oct 1;17(10):1166-1172. doi: 10.6004/jnccn.2019.7303.

PMID:
31590146
25.

Time-varying effects of family smoking and family management on adolescent daily smoking: The moderating roles of behavioral disinhibition and anxiety.

Steeger CM, Epstein M, Hill KG, Kristman-Valente AN, Bailey JA, Lee JO, Kosterman R.

Drug Alcohol Depend. 2019 Nov 1;204:107572. doi: 10.1016/j.drugalcdep.2019.107572. Epub 2019 Sep 21.

PMID:
31585356
26.

Muscle acetylcholine receptor conversion into chloride conductance at positive potentials by a single mutation.

Cetin H, Epstein M, Liu WW, Maxwell S, Rodriguez Cruz PM, Cossins J, Vincent A, Webster R, Biggin PC, Beeson D.

Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):21228-21235. doi: 10.1073/pnas.1908284116. Epub 2019 Sep 30.

27.

An intergenerational investigation of the associations between parental marijuana use trajectories and child functioning.

Epstein M, Bailey JA, Furlong M, Steeger CM, Hill KG.

Psychol Addict Behav. 2019 Sep 9. doi: 10.1037/adb0000510. [Epub ahead of print]

PMID:
31497987
28.

Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research Network.

Burnett-Hartman AN, Udaltsova N, Kushi LH, Neslund-Dudas C, Rahm AK, Pawloski PA, Corley DA, Knerr S, Feigelson HS, Hunter JE, Tabano DC, Epstein MM, Honda SA, Ter-Minassian M, Lynch JA, Lu CY.

JCO Clin Cancer Inform. 2019 Sep;3:1-10. doi: 10.1200/CCI.19.00026.

29.

Neuropsychiatric phenotypes and a distinct constellation of ASD features in 3q29 deletion syndrome: results from the 3q29 registry.

Pollak RM, Murphy MM, Epstein MP, Zwick ME, Klaiman C, Saulnier CA; Emory 3q29 Project, Mulle JG.

Mol Autism. 2019 Jul 16;10:30. doi: 10.1186/s13229-019-0281-5. eCollection 2019.

30.

Pathfinding, Progress and Partnerships: Commentary on the JACM Whole Systems Research Special Issue.

Epstein M.

J Altern Complement Med. 2019 Aug;25(8):775-776. doi: 10.1089/acm.2019.0179. Epub 2019 Jul 1. No abstract available.

PMID:
31260332
31.

Future Considerations in Nocturia and Nocturnal Polyuria.

Weiss JP, Monaghan TF, Epstein MR, Lazar JM.

Urology. 2019 Nov;133S:34-42. doi: 10.1016/j.urology.2019.06.014. Epub 2019 Jun 22. Review.

32.

TIGAR: An Improved Bayesian Tool for Transcriptomic Data Imputation Enhances Gene Mapping of Complex Traits.

Nagpal S, Meng X, Epstein MP, Tsoi LC, Patrick M, Gibson G, De Jager PL, Bennett DA, Wingo AP, Wingo TS, Yang J.

Am J Hum Genet. 2019 Aug 1;105(2):258-266. doi: 10.1016/j.ajhg.2019.05.018. Epub 2019 Jun 20.

33.

Overview of in vivo and ex vivo endpoints in murine food allergy models: Suitable for evaluation of the sensitizing capacity of novel proteins?

Castan L, Bøgh KL, Maryniak NZ, Epstein MM, Kazemi S, O'Mahony L, Bodinier M, Smit JJ, van Bilsen JHM, Blanchard C, Głogowski R, Kozáková H, Schwarzer M, Noti M, de Wit N, Bouchaud G, Bastiaan-Net S.

Allergy. 2020 Feb;75(2):289-301. doi: 10.1111/all.13943. Epub 2019 Jul 9. Review.

34.

Comparison of nocturia etiology in black and white male patients.

Epstein MR, Monaghan TF, Khusid JA, Suss NR, Agudelo CW, Michelson KP, Wu ZD, Gong F, Weiss JP.

Can J Urol. 2019 Jun;26(3):9769-9773.

PMID:
31180307
35.

Ragweed pollen and allergic symptoms in children: Results from a three-year longitudinal study.

Jones NR, Agnew M, Banic I, Grossi CM, Colón-González FJ, Plavec D, Goodess CM, Epstein MM, Turkalj M, Lake IR.

Sci Total Environ. 2019 Sep 15;683:240-248. doi: 10.1016/j.scitotenv.2019.05.284. Epub 2019 May 21.

PMID:
31132703
36.

Effectiveness of Facebook Groups to Boost Participation in a Parenting Intervention.

Epstein M, Oesterle S, Haggerty KP.

Prev Sci. 2019 Aug;20(6):894-903. doi: 10.1007/s11121-019-01018-0.

PMID:
31124023
37.

Th2-TRMs Maintain Life-Long Allergic Memory in Experimental Asthma in Mice.

Bošnjak B, Kazemi S, Altenburger LM, Mokrović G, Epstein MM.

Front Immunol. 2019 Apr 24;10:840. doi: 10.3389/fimmu.2019.00840. eCollection 2019.

38.

Powerful and Efficient Strategies for Genetic Association Testing of Symptom and Questionnaire Data in Psychiatric Genetic Studies.

Holleman AM, Broadaway KA, Duncan R, Todor A, Almli LM, Bradley B, Ressler KJ, Ghosh D, Mulle JG, Epstein MP.

Sci Rep. 2019 May 17;9(1):7523. doi: 10.1038/s41598-019-44046-0.

39.

Opioid and Substance Use Disorder and Receipt of Treatment Among Parents Living With Children in the United States, 2015-2017.

Clemans-Cope L, Lynch V, Epstein M, Kenney GM.

Ann Fam Med. 2019 May;17(3):207-211. doi: 10.1370/afm.2389.

40.

The relevance of a digestibility evaluation in the allergenicity risk assessment of novel proteins. Opinion of a joint initiative of COST action ImpARAS and COST action INFOGEST.

Verhoeckx K, Bøgh KL, Dupont D, Egger L, Gadermaier G, Larré C, Mackie A, Menard O, Adel-Patient K, Picariello G, Portmann R, Smit J, Turner P, Untersmayr E, Epstein MM.

Food Chem Toxicol. 2019 Jul;129:405-423. doi: 10.1016/j.fct.2019.04.052. Epub 2019 May 4.

41.

Genomic Classifiers for Treatment Selection in Newly Diagnosed Prostate Cancer.

Fine ND, LaPolla F, Epstein M, Loeb S, Dani H.

BJU Int. 2019 May 4. doi: 10.1111/bju.14799. [Epub ahead of print] Review.

PMID:
31055874
42.

Epilepsy in families: Age at onset is a familial trait, independent of syndrome.

Ellis CA, Churilov L, Epstein MP, Xie SX, Bellows ST, Ottman R, Berkovic SF; Epi4K Consortium.

Ann Neurol. 2019 Jul;86(1):91-98. doi: 10.1002/ana.25499. Epub 2019 May 20.

PMID:
31050039
43.

Beyond the Label: Ensuring That Drug Benefits Outweigh Risks in the Food and Drug Administration's Risk Evaluation and Mitigation Strategy Program.

Epstein MS, Shah ED, Deepak P, Kushnir VM.

Am J Gastroenterol. 2019 Jul;114(7):1017-1019. doi: 10.14309/ajg.0000000000000215. No abstract available.

PMID:
31033521
44.

Connecting experts in the agricultural and meteorological sciences to advance knowledge of pest management in a changing climate.

Young SL, Goldowsky-Dill NW, Muhammad J, Epstein MM.

Sci Total Environ. 2019 Jul 10;673:694-698. doi: 10.1016/j.scitotenv.2019.04.126. Epub 2019 Apr 10.

PMID:
31003096
45.

Rare variants in MYH15 modify amyotrophic lateral sclerosis risk.

Kim H, Lim J, Bao H, Jiao B, Canon SM, Epstein MP, Xu K, Jiang J, Parameswaran J, Li Y, Moberg KH, Landers JE, Fournier C, Allen EG, Glass JD, Wingo TS, Jin P.

Hum Mol Genet. 2019 Jul 15;28(14):2309-2318. doi: 10.1093/hmg/ddz063.

PMID:
30985904
46.

The Healthcare Systems Research Network (HCSRN) as an Environment for Dissemination and Implementation Research: A Case Study of Developing a Multi-Site Research Study in Precision Medicine.

Rahm AK, Ladd I, Burnett-Hartman AN, Epstein MM, Lowery JT, Lu CY, Pawloski PA, Sharaf RN, Liang SY, Hunter JE.

EGEMS (Wash DC). 2019 Apr 12;7(1):16. doi: 10.5334/egems.283.

47.

Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis.

Poordad F, Sedghi S, Pockros PJ, Ravendhran N, Reindollar R, Lucey MR, Epstein M, Bank L, Bernstein D, Trinh R, Krishnan P, Polepally AR, Unnebrink K, Martinez M, Nelson DR.

J Viral Hepat. 2019 Aug;26(8):1027-1030. doi: 10.1111/jvh.13109. Epub 2019 May 6.

48.

Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletion.

Rutkowski TP, Purcell RH, Pollak RM, Grewenow SM, Gafford GM, Malone T, Khan UA, Schroeder JP, Epstein MP, Bassell GJ, Warren ST, Weinshenker D, Caspary T, Mulle JG.

Mol Psychiatry. 2019 Apr 11. doi: 10.1038/s41380-019-0413-5. [Epub ahead of print]

49.

Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients.

Clarke CL, Kushi LH, Chubak J, Pawloski PA, Bulkley JE, Epstein MM, Burnett-Hartman AN, Powell B, Pearce CL, Spencer Feigelson H.

Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):996-999. doi: 10.1158/1055-9965.EPI-18-1324. Epub 2019 Apr 9.

PMID:
30967418
50.

Overnight Urge Perception in Nocturia Is Independent of Depression, PTSD, or Anxiety in a Male Veterans Administration Population.

Monaghan TF, Bliwise DL, Suss NR, Epstein MR, Wu ZD, Michelson KP, Agudelo CW, Robins DJ, Wagg A, Weiss JP.

J Clin Sleep Med. 2019 Apr 15;15(4):615-621. doi: 10.5664/jcsm.7726.

PMID:
30952224

Supplemental Content

Loading ...
Support Center